EDE approves once-daily Rinvoq for UAE vitiligo patients aged 12+
The UAE is the first market to approve oral Rinvoq for non-segmental vitiligo. Clinics and insurers now face pricing, eligibility and monitoring questions.

We make finding a doctor in the UAE free, transparent, and easy.